Home infusion startup HealthIV launches to curb dehydration, hangovers

The service also offers a COVID-19 test at home.
By Laura Lovett
02:43 pm
Share

Photo: Juan Napurí/Getty Images

A new company is looking to use digital tools to help users curb dehydration and cure hangovers. This morning a digital health company focused on delivering at-home infusion therapies, dubbed HealthIV, launched. 

The company has a digital platform that lets users book an appointment for a nurse to come to the home for an infusion therapy focused on a variety of services including hydration, hangover, energy lift, recovery, the flu, immune boost and more. The services are $129 per visit, except for an NAD+ infusion, which will set users back $599. There is also a membership option that costs users $99 per month. 

Customers are also able to add on a PCR or antigen COVID-19 test for $19, and boosters such as Zinc and Vitamin C, which also cost an extra $19. 

WHY IT MATTERS 

Dehydration is fairly common and can be caused by not drinking enough water, as well as diarrhea, vomiting, fever or increased urination, according to the Mayo Clinic. Infants, older adults and people with chronic illnesses are especially at risk for the condition, according to the health system. 

The condition can lead to heat injury, urinary and kidney problems, seizures and low blood volume shock. 

The company is pitching its tool as a way to help folks access intravenous fluids in their home. 

THE LARGER TREND 

Several digital health companies have been moving into the home care space. In December direct-to-consumer company Ro announced its acquisition of Workpath, a tool that can offer on-demand in-home care services through an API. 

California-based Heal is a platform that helps doctors coordinate house calls. In 2020, the company snagged $100 million from Humana as part of a strategic partnership. This Series D investment boosted the company’s total raise to $170 million.

DispatchHealth has also created a platform that lets patients request an on-demand care visit in their home. In March, the company landed $200 million in Series D financing, boosting its valuation to $1.7 billion. 

 
Tags: 
IV, HealthIV
Share